(Q36125352)

12 August 2017

1 reference

title

Genetic and physiological insights into the metabolic syndrome (English)

1 reference

12 August 2017

1 reference

1

Robert A Hegele

0 references

Rebecca L Pollex

series ordinal

2

object named as

Rebecca L Pollex

1 reference

12 August 2017

publication date

12 May 2005

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

12 August 2017

published in

1 reference

12 August 2017

volume

289

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

R663-9

1 reference

A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

HIV-Associated Lipodystrophy: Pathogenesis and Clinical Features

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Pharmacotherapy for dyslipidaemia – current therapies and future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

The human phenome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Phenomics: fiction or the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

The prevalence of NIDDM and associated risk factors in native Canadians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Phenomics, lipodystrophy, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Premature atherosclerosis associated with monogenic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Unbuckling lipodystrophy from insulin resistance and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Development of the multiple metabolic syndrome: an epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

The laminopathies: nuclear structure meets disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Genetics of complex disease: approaches, problems, and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

The metabolic syndrome: practical guide to origins and treatment: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

The metabolic syndrome: a practical guide to origins and treatment: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Childhood obesity in a population at high risk for type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00275.2005

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1152/AJPREGU.00275.2005

15 July 2023

Identifiers

DOI

1 reference

12 August 2017

1 reference